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INTRODUCTION
Point-of-care testing (POCT) is becoming an important
adjunct to haematology laboratory practice. Apart from
its use in hospital out-patient and intensive care/critical
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SUMMARY
Point-of-care testing (POCT) is becoming an important adjunct to
haematology laboratory practice. An important component of the
blood count is the total white cell count (WBC). Previously, this
required laborious microscopic cell counting, but it can now be
performed by means of automation; however, in many under-
resourced countries, costly automated counters are only available in
very few central hospitals. Moreover, neither method is practical in
most POCT situations. The HemoCue WBC has been developed as a
simpliﬁed alternative method, consisting of a reagent pre-loaded
disposable cuvette together with basic image analysis technology. This
report describes an assessment of its utility. The WBC of 500 routine
blood samples from the hospital were tested in parallel by the HemoCue
WBC and by a reference analyser to assess accuracy and utility of the
former. The tests included precision, linearity, type of blood sample and
anticoagulant and potential interfering substances in blood specimens.
In the tests for accuracy, 192 of the 200 showed percentage difference
from the NEQAS reference of <10% whilst the remaining eight
samples differed by <12%, thus meeting the requirements of Clinical
laboratory improvement amendments (CLIA)-88 regulations. Of the
samples tested with potential interfering substances only those with
>2% normoblasts or reticulocytosis showed signiﬁcant differences from
the reference measurements. The HemoCue WBC is reliable for WBC
counts within the analytical range of 0.4–30.0 · 10
9/l, except in
samples where there are significant numbers of normoblasts or
reticulocytes. It is simple to use and provides a valuable advance in
the facilities available for POCT in haematology.
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tests to be undertaken at primary health centre clinics
or in general practice (Lewis, Osei-Bimpong & Brad-
shaw, 2004) and it is particularly useful when patients
live a distance away from a hospital laboratory.
Guidelines on the organization of POCT in haematology
have been published, inter alia, by the British Commit-
tee for Standards in Haematology (England et al., 1995)
and the International Council for Standardization in
Haematology (Briggs et al., 2008). Several haematologi-
cal tests are appropriate for POCT, especially measure-
ment of haemoglobin by simple portable photometers,
including those developed by HemoCue (Von Schenck,
Falkebsson & Lundberg, 1985; Neville, 1987; Morris,
Pont & Lewis, 2001).
Another important component of the blood count
is the total white cell count (WBC). Previously, this
required laborious microscopic counting of diluted
blood in a counting chamber, but it can now be per-
formed by means of an automated blood cell counter.
However, in many under-resourced countries; costly
automated counters are only available in very few
central hospitals and other larger laboratories (Bates &
Mendelow, 2006). Neither method is practical in
smaller clinics, nor in most POCT situations, including
general practice.
To overcome this problem, HemoCue AB has
developed a new portable system (HemoCue WBC,
Figure 1). It consists of a microscopic image detector
(photomicroscope), a cuvette holder and an LCD dis-
play unit; it is powered by six AA batteries or an AC
6 volt adapter, and is as simple to use as the haemoglo-
binometers. Approximately 10 ll of peripheral capillary
blood or venous blood in any anticoagulant is drawn
into a plastic cuvette containing a reagent where the
red cells are haemolysed and the nuclei of the white
cells stained by methylene blue. In the analyser, an
image is captured by the photomicroscope (Figure 2)
and after 2 min, the image analysis programme counts
the stained white cell nuclei, ‘gating out’ platelets that
are much smaller than white cells. The WBC is then
expressed on the LCD as the WBC · 10
9/l.
The instrument is designed to measure WBC
counts between 0.4 and 35.0 · 10
9/l, beyond this
limit, a ﬂag is triggered; an LLL ﬂag appears on the
display to denote a count below its counting capability
when the WBC is <0.4 · 10
9/l and an HHH ﬂag is
triggered when the count is higher than 35.0 · 10
9/l
to indicate a WBC count above its counting capability.
The instructions are easy to follow and after a short
‘hands-on’ trial the instrument could be used without
any problems even by persons with no previous expe-
rience in laboratory technology.
This study was undertaken to assess the reliability
and clinical utility of the device in accordance with
the recommendations of the International Council for
Standardization in Haematology (1994) and taking
account of the requirements established by UK NE-
QAS that for the WBC counts to be acceptable the
results must be within 8–10% of assigned values
Figure 1. Photograph of the portable HemoCue WBC
Point-of-care analyser (plastic cuvette containing a
drop of blood is shown placed on the circular base
holder).
Figure 2. Microscopic appearance of a cuvette ﬁlled
with a blood sample. (·40) Photographed on a con-
ventional light microscope (Nikon E400; Nikon Elec-
tronic Company, Osaka, Japan).
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oratory improvement amendments (CLIA)-88 require-
ment that results within 15% of assigned value are
clinically acceptable (US Federal register, 1992).
Accordingly, in the present study assessments were
made at these cut-off points.
Whilst this device is intended primarily for use with
capillary blood, for the purpose of this study, it was
logistically more practical to use venous blood samples
collected into EDTA. A previous study showed no sig-
niﬁcant differences in the WBC between venous and
capillary blood (Yang et al., 2001) and the Inter-
national Council for Standardization in Haematology
and International Society for Hematology have also
established that there are negligible differences in
blood count parameters between venous blood and
capillary blood provided that the capillary sample is
obtained from free ﬂow of the blood without sque-
ezing, and after discarding of the ﬁrst drop (Tatsumi
et al., 2002). Although this is not strictly relevant to an
assessment of the ability of the HemoCue WBC to
measure the WBC in the sample presented to it, in
order to provide assurance on its utility for measuring
capillary blood in practice, a comparison of results
between the two procedures was assessed on a limited
number of volunteer laboratory staff.
METHODS
The study assessed the manufacturer’s claims that
accuracy and linearity are within 6% of the true val-
ues in the range 0.3–35 · 10
9/l. The evaluation
included tests for precision, comparability, accuracy,
stability, and any interference to the WBC by various
factors such as nucleated red cells, and disease states
such as leukaemia, lymphoma and iron deﬁciency. In
addition to routine specimen collection in dipotassi-
um–EDTA, 50 specimens were also collected in tripo-
tassium–EDTA and in sodium citrate to assess any
signiﬁcant differences because of the anticoagulant.
Samples were obtained from 500 blood specimens
in dipotassium–EDTA anticoagulant that had been
sent to the laboratory for routine blood counts. Refer-
ence counts were obtained by a standardized Sysmex
XE-2100 analyser (Sysmex Corporation, Kobe, Japan).
Comparisons between HemoCue WBC and the reference
analyser were assessed in several groups, namely
WBC below normal, within normal range, above
normal range, and at borderline between normal and
abnormal. To take account of the limits of acceptable
performance established by NEQAS and by CLIA-88
(International Council for Standardization in Haema-
tology, 1994; Morris, Pont & Lewis, 2001), special
note was made of any differences from the reference
at 6%, 8–10% and 15%, respectively.
To assess the effect of sample type, WBC measure-
ments were made on blood from eight laboratory staff
volunteers from whom the samples were obtained by
ﬁnger prick in parallel with venous blood collected in
EDTA.
Linearity studies were carried out by serially dilut-
ing a blood specimen with a WBC of 30.0 · 10
9/l one
in two up to one in 16 volumes of isotonic saline. The
WBC was then performed on each sample by the
HemoCue WBC and by the reference analyser.
The ﬂagging capability of the HemoCue WBC was
also assessed; the trigger factors and their sensitivity
levels were noted during the evaluation of accuracy
and linearity.
TheeffectofcuvettestoragetemperatureontheWBC
results was assessed by testing samples with cuvettes
storedat4  C,roomtemperature(22  C)and37  C.
Statistical methods
All the data were analysed using Excel software statis-
tics package analysis software (MICROSOFT OFFICE EXCEL
2003; Microsoft Corporation, Redmond, WA, USA);
the mean, range and student paired t-tests were calcu-
lated using this package; P-values < 0.05 were consid-
ered signiﬁcant.
RESULTS
Precision
Mean values, ranges, standard deviation and CVs
were established on ﬁve replicate tests at eight differ-
ent levels of WBC (Table 1).
Comparability
White cell counts on 200 samples were performed on
the HemoCue WBC and the reference analyser; the data
were assessed for comparability which is graphically
represented in Figure 3.
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White cell counts were performed with the HemoCue
WBC on blood from eight volunteers, comparing sam-
ples obtained by ﬁnger prick to those from venous
blood. Paired results are shown in Figure 4. Measure-
ments did not vary by >5% in any case and no bias
was detected. It was concluded that there was no sig-
niﬁcant difference between the two methods of speci-
men collection (P = 0.105).
These ﬁndings indicate good linearity within the
manufacturer’s suggested analytic range with no
detectable bias. There was no signiﬁcant difference in
the linearity of the HemoCue WBC in comparison to
the reference analyser (P = 0.475; Table 2).
Accuracy
The accuracy of the HemoCue WBC was assessed by
500 counts at various ranges in comparison with the
reference analyser. The numbers of paired results
within and outside clinically acceptable limits (see
above) are shown in Table 3.
Only three of the 110 samples tested with WBC
values below the normal range showed a variation of
>10% from the reference counter; however, in these
three cases, the variation was <12%. In the group
with counts within the normal range, 71 samples
correlated to the reference count to within a 10% dif-
ference, whilst 17 were within the clinically accept-
Table 1. Precision data showing degree of variation of
HemoCue WBC values over a range of white blood cell
counts
Replicate
mean WBC
· 10
9/l (n =5 )
WBC range
· 10
9/l CV (%) SD · 10
9/l
0.7 0.5–0.8 11 0.08
1.5 1.4–1.7 8.6 0.13
3.7 3.4–3.9 3.0 0.11
5.5 5.0–6.1 4.5 0.25
8.5 8.2–8.8 2.2 0.19
14.3 13.1–15.2 3.3 0.47
21.2 20.6–21.9 2.8 0.59
27.4 26.0–28.4 2.0 0.54
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Figure 3. Correlation between the reference analyser
and the HemoCue WBC. Y = 0.989X)0.082 (Y = refer-
ence analyser and X = HemoCue WBC). The
correlation coefﬁcient (r) between 0.4 · 10
9/l and
30 · 10
9/l = 0.997. These ﬁndings indicate good
comparability within the manufacturer’s suggested
analytic range with no detectable bias.
Table 2. Linearity serial dilutions of a sample with
initial WBC = 30.0 · 10
9/l
Dilution
Reference analyser
count · 10
9/l
HemoCue WBC
count · 10
9/l
Neat 30.0 29.8
1:2 14.9 14.5
1:4 10.6 10.0
1:8 5.8 6.0
1:16 3.4 3.1
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Figure 4. Comparison of HemoCue WBC measurements
on capillary and venous blood samples:
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counts above the normal range, 98% of counts were
within a 10% difference whilst the remainder fell
within a difference of 15%.
The accuracy studies also included measurement
on two NEQAS survey samples. The ﬁrst sample gave
a HemoCue WBC count of 0.9 · 10
9/l, as compared
with the participants all-methods mean (n = 1500) of
1 · 10
9/l. On the second sample, the HemoCue WBC
count was 3.9 · 10
9/l whilst the participant all-meth-
ods mean was 4.0 · 10
9/l. These results gave a highly
satisfactory performance by the HemoCue WBC with
deviation index scores of <0.5 for both samples.
Stability
The mean and median of the WBC obtained using cu-
vettes equilibrated to three different temperatures are
shown in Table 4.
There was no statistical difference between the He-
moCue WBC results and the reference values at the
three temperatures, indicating that HemoCue WBC
counts showed no variation with alteration to the rec-
ommended cuvette storage temperature.
Anticoagulants
Effects of the type of anticoagulant on the count were
evaluated on samples that had been collected in sodium
citrate and tripotassium–EDTA anticoagulants as well
as in the recommended dipotassium–EDTA. There were
no signiﬁcant differences in the counts from different
specimen containers and results showed a good correla-
tion with the reference counts (Table 5).
Table 3. Accuracy showing percentage difference of
HemoCue WBC values from reference count
WBC
range
· 10
9/l
Number of
samples
analysed
<10%
difference
>10%
< 15%
difference
>15%
difference
0.1*–4.0 110 107 3 0
4.1–10.0 88 71 17 0
>10.0–12.0 109 108 1 0
>12.0 93 91 2 0
>12–15 38 37 1 0
>15–20 34 33 1 0
>20–30** 28 27 1 0
*Samples with the reference WBC <0.4 were ﬂagged as
low with an error code: LLL.
**Samples with the reference WBC >30 were ﬂagged as
high with an error code: HHH.
Table 4. Comparison of HemoCue
WBC values against reference ana-
lyser at different temperatures
Reference
WBC · 10
9/l
4  C HemoCue
WBC · 10
9/l,
P=0.437*
22  C HemoCue
WBC · 10
9/l,
P = 0.525*
37  C HemoCue
WBC · 10
9/l,
P = 0.234*
Range 1.6–19.5 1.7–18.9 1.5–19.6 1.5–19.3
Mean 10.7 10.7 10.6 10.7
Median 10.4 10.3 10.1 10.7
*P-value is shown for comparison between HemoCue WBC and corresponding
reference WBC.
Table 5. Comparison of HemoCue WBC values using different anticoagulants
n
Citrate
reference
Citrate
HemoCue
P = 0.426
K2EDTA
reference
K2EDTA
HemoCue
P = 0.359
K3EDTA
reference
K3EDTA
HemoCue
P=0.525
Mean WBC · 10
9/l 50 9.7 9.8 9.9 9.9 9.8 9.9
Median WBC · 10
9/l 50 9.8 9.7 9.8 9.8 9.9 9.8
*P-value is shown for comparison between HemoCue WBC and corresponding reference WBC.
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The possibility was assessed of interference with the
WBC by the presence of other types of cells (reticulo-
cytes, nucleated red cells) thrombocytosis and certain
other abnormal blood conditions, as listed in Table 6.
The mean HemoCue WBC count was signiﬁcantly
higher than the mean reference count (P < 0.001) in
patients with sickle cell disease or thalassaemia major
with signiﬁcant numbers of normoblasts (i.e. >2%).
The HemoCue WBC mean count was also signiﬁcantly
higher in samples where there was a reticulocytosis:
>100 · 10
9/l as counted by the reference analyser and
subsequently conﬁrmed by blood ﬁlm morphology.
There were no ﬂags generated by the analyser to alert
the user to these discrepant results.
However, the platelet count, even at the high lev-
els in thrombocytosis (1000 · 10
9/l), had no inﬂuence
on the HemoCue WBC results (P = 0.17), and reliable
WBC counts were also obtained in iron deﬁciency,
lymphoma and myeloma.
DISCUSSION
There has been a long-felt need for a method to
obtain white blood cell counts at point-of-care that
could be as useful for patient management as the
well-established methods for haemoglobinometry. It is
essential that such a device should be simple to oper-
ate, unaffected by various climatic conditions and suf-
ﬁciently accurate for reliable clinical use.
Our study has indicated that these requirements are
provided by the HemoCue WBC system as described
above. This portable device is simple to use, even by
persons with no previous experience in laboratory
technology. Although the HemoCue WBC does not per-
form a differential count, a basic WBC (especially when
linked to haemoglobin) will often help expedite clinical
management. Furthermore, as primary healthcare units
in under-resourced rural areas often have the facility of
microscopy (Bates & Mendelow, 2006), an abnormal
WBC would be an indication for examination of a blood
ﬁlm and a differential leucocyte count.
The extensive assessment of the utility and reli-
ability of the HemoCue WBC described in this paper
has shown good precision for replicate measure-
ments on blood samples over a range of WBC
counts and good comparability with results obtained
by more sophisticated blood count analysers. For
assessment of accuracy, results were compared with
those measured by a calibrated reference blood cell
analyser: 94.8% of the samples tested were within
the acceptable performance limits of 8–10% of the
correct measurements as required by UK NEQAS
(Lewis & De la Salle, 2006), and in no case was the
difference >12%, so that all were acceptable in
accordance with the CLIA-88 requirement that
results should be within 15% (US Federal register,
1992). Thus, the small differences from the refer-
ence measurement would not be clinically mislead-
ing and especially when results are considered in
absolute numbers rather than percentages. Further-
more, tests on two samples in UK NEQAS surveys
gave results very close to the overall mean values
for these surveys.
In our study, the device provided reliable compara-
bility in the range of 0.4–30.0 · 10
9/l. This is slightly
narrower than the range of 0.3–35 · 10
9/l speciﬁed
Table 6. Comparison of WBC
values for various conditions and
interference
Disease/condition n
HemoCue WBC
mean (·10
9/l)
Reference count
mean(·10
9/l) P-value
Sickle cell disease 30 10.6 9.2 <0.001
Iron deﬁciency anaemia 35 9.8 9.7 0.134
Acute leukaemia 35 35.1 30.0 <0.001
Chronic leukaemia 32 40.0 36.0 <0.001
Lymphoma 30 20.0 19.6 0.187
Myeloma 31 15.6 15.3 0.216
Reticulocytosis
(>100 · 10
9/l)
25 10.8 9.2 <0.001
Thalassemia with
nucleated red cells
30 11.2 9.8 <0.001
Thrombocytosis 35 9.1 9.2 0.175
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WBC < 0.4 · 10
9/l were ﬂagged as low (code LLL)
and conversely, those with counts above 30.0 · 10
9/l
were ﬂagged as high (code HHH); thus, in a clinical
setting, this ﬂagging would provide adequately reliable
information.
Special note should be taken of the cases recorded
in Table 6 where measurements may be distorted by
speciﬁc interfering substances, notably reticulocytosis
and more than 2% circulating normoblasts. Haemo-
globinopathies (especially sickle cell disease and thal-
assaemia major) were identiﬁed as the main cause of
falsely high counts, because of two factors: (i) the
image analysis programme does not distinguish nucle-
ated red cells from the total WBC, and (ii) as reticulo-
cytes have a greater resistance to lysis than mature
red cells (Sadallah, Hano & Schiferlli, 2007). The 2-
min reaction of the sample with the lytic reagent in
the cuvette may not be adequate in these circum-
stances. The restriction of the ﬂagging capability of
the Hemocue WBC analyser to extreme WBCs (<0.4
and >30.0 · 10
9/l) is a major limitation of the device;
no ﬂags are generated to alert the user to increased
numbers of reticulocytes and normoblasts. Therefore,
in view of the discrepancies in the white blood counts
which were found in blood samples of patients with
sickle cell disease and thalassaemia, care must be
taken in interpreting the HemoCue WBC measurements
in regions where these conditions are prevalent. How-
ever, even there, the method provides a clinically use-
ful approximation of the WBC.
In a limited study, the sample type (venous or cap-
illary blood) did not make any difference to the WBC.
Stability studies were also carried out to assess the
effects of different local practice and climatic condi-
tions. It was shown that tests were not affected when
the cuvettes were stored at temperatures between
4 and 37  C; nor were they inﬂuenced by different
anticoagulants.
CONCLUSION
The total white cell count (WBC) was recognized as
an important test for health screening and for
diagnosis and clinical management of patients. This
study has demonstrated that the newly developed
HemoCue WBC provides a simple method to obtain
reliable measurements with an accuracy that is
comparable with that of a standardized reference ana-
lyser. It is, thus, eminently suitable for use in any
point-of-care situations with limited or no laboratory
facilities, especially in general practice and in rural
clinics without access to modern blood count analy-
sers provided that the users appreciate that in patients
with sickle cell anaemia or thalassaemia, and also
when there are signiﬁcant numbers of reticulocytes or
normoblasts in circulation, the WBC may give an
inaccurate reading. However, even so, the method
will provide a clinically useful approximation of the
WBC.
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